Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214181) titled 'Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome' on Oct. 2.

Study Type: Observational [Patient Registry]

Primary Sponsor: Universidad de Murcia

Condition: Burning Mouth Syndrome Stomatodynia

Intervention: Drug: Topical amitriptyline 1% gel

Recruitment Status: Not recruiting

Date of First Enrollment: January 2, 2024

Target Sample Size: 30

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT07214181

Published by HT Digital Content Services with permission from Health Daily Digest....